Synapse - Clifford Hudis

Search Within

Clifford Hudis

Results (906)

Preliminary results from a phase 2 single-arm study of enzalutamide, an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)

Meeting Abstract

Traina, T. A.; O'Shaughnessy, J.; Nanda, R.; Schwartzberg, L.; Abramson, V.; Cortes, J.; Peterson, A.; Tudor, I. C.; Blaney, M.; Steinberg, J. L.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Impact of intrinsic subtype by PAM50 and other gene signatures on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) or bevacizumab (Bev): CALGB 40603/150709 (Allianc

Meeting Abstract

Sikov, W. M.; Barry, W. T.; Hoadley, K. A.; Pitcher, B. N.; Singh, B.; Tolaney, S. M.; Kuzma, C. S.; Pluard, T. J.; Somlo, G.; Port, E. R.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Phase I, open-label study evaluating the safety and tolerability of LJM716, BYL719 and trastuzumab in patients with metastatic HER2+ breast cancer

Meeting Abstract

Shah, P. D.; Chandarlapaty, S.; Ulaner, G.; Zamora, S.; Sterlin, V.; Iasonos, A.; Dickler, M. N.; Moynahan, M. E.; Hudis, C. A.; Baselga, J.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Meeting Abstract

Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; more...
Cancer Research (2015)

Fulltext@MSK | Save

The genomic landscape of male breast cancers

Meeting Abstract

Piscuoglio, S.; Murray, M.; Ng, C. K. Y.; Rocco, E. G.; Martelotto, L. G.; Bidard, F. C.; Eberle, C. A.; Fusco, N.; Sakr, R. A.; De Mattos-Arruda, L.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Prognostic and predictive implications of monosomy 17 in curable HER2-amplified breast cancer

Meeting Abstract

Page, D.; Wen, Y. H.; Dure, D.; Hudis, C.; Brogi, E.; Mcarthur, H.
Cancer Research (2015)

Fulltext@MSK | Save

Integrated immunologic assessment of tumor infiltrating lymphocytes (TILs) and peripheral blood to assess synergy of cryoablation (cryo) plus ipilimumab (ipi) in early stage breast cancer (ESBC) patients (pts)

Meeting Abstract

Page, D.; Yuan, J. D.; Diab, A.; Dong, Z.; Ginsberg, A.; Wong, P.; Emerson, R.; Redmond, D.; Blum, B.; Mu, Z.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Alliance A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A phase III study

Meeting Abstract

Ma, C. X.; Suman, V.; Leitch, A. M.; Sanati, S.; DeSchryver, K.; Unzeitig, G. W.; Haluska, P.; Watson, M.; Hahn, O.; Zujewski, J. A.; more...
Cancer Research (2015)

Fulltext@MSK | Save

A phase I clinical trial of ganetespib (heat shock protein 90 inhibitor) in combination with paclitaxel and trastuzumab in human epidermal growth factor receptor-2 positive (HER2+) metastatic breast cancer

Meeting Abstract

Jhaveri, K.; Cadoo, K.; Chandarlapaty, S.; Teplinsky, E.; Speyer, J.; D'Andrea, G.; Patil, S.; Haque, S.; Friedman, K.; Heese, S.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Both metabolic syndrome and statin use are more common in women with breast inflammation

Meeting Abstract

Iyengar, N. M.; Gucalp, A.; Zhou, X. K.; Howe, L. R.; Morris, P. G.; Giri, D.; Subbaramaiah, K.; Bhardwaj, P.; Park, S. S.; Pollak, M.; more...
Cancer Research (2015)

Fulltext@MSK | Save